Exploring the costs of a limited public sector antiretroviral treatment programme in South Africa

Boulle, A; Kenyon, C; Skordis, J; Wood, R; (2002) Exploring the costs of a limited public sector antiretroviral treatment programme in South Africa. South African Medical Journal, 92 (10). pp. 811-7. ISSN 0256-9574

Full text not available from this repository.


BACKGROUND: The role of antiretroviral treatment for adults in the pubic sector in South Africa is debated with little consideration of programme choices that could impact on the cost-effectiveness of the intervention. This study seeks to explore the impact of these programme choices at an individual level, as well as explore the total cost of a rationed national public sector antiretroviral treatment programme. METHODS: Eight scenarios were modelled of limited national treatment programmes over the next 5 years, reflecting different programme design choices. The individual cost-effectiveness of these scenarios were compared. The total costs of the most cost-effective scenario were calculated, and the potential for savings in other areas of health care utilisation was explored. RESULTS: The direct programme costs per life-year saved varied between scenarios from R5,923 to R11,829. All the costs of the most cost-effective scenario could potentially be offset depending on assumptions of health care access and utilisation. The total programme costs for the most cost-effective scenario in 2007 with 107,000 people on treatment are around R409 million. CONCLUSION: Specific policy choices could almost double the number of people who could benefit from an investment in a limited national antiretroviral treatment programme. Such a programme is affordable within current resource constraints. The consideration of antiretroviral treatment calls for a unique public health approach to the rationing of health services in the public sector.

Item Type: Article
Keywords: Adult, Anti-HIV Agents/*economics, Cost Savings, Cost of Illness, Cost-Benefit Analysis, Direct Service Costs/statistics & numerical data, Drug Costs/statistics & numerical data, Drug Monitoring/economics, HIV Infections/drug therapy/economics/mortality, Health Care Costs/statistics & numerical data, Health Care Rationing/economics, Health Services Research, Human, Models, Econometric, National Health Programs/*economics, Program Evaluation, Public Health Practice/*economics, Public Sector/*economics, South Africa/epidemiology, Value of Life/economics, Adult, Anti-HIV Agents, economics, Cost Savings, Cost of Illness, Cost-Benefit Analysis, Direct Service Costs, statistics & numerical data, Drug Costs, statistics & numerical data, Drug Monitoring, economics, HIV Infections, drug therapy, economics, mortality, Health Care Costs, statistics & numerical data, Health Care Rationing, economics, Health Services Research, Humans, Models, Econometric, National Health Programs, economics, Program Evaluation, Public Health Practice, economics, Public Sector, economics, South Africa, epidemiology, Value of Life, economics
Faculty and Department: Faculty of Public Health and Policy > Dept of Global Health and Development
PubMed ID: 12432807
Web of Science ID: 178774000027
URI: http://researchonline.lshtm.ac.uk/id/eprint/11150


Download activity - last 12 months
Downloads since deposit
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item